FDA Inspection 1236667 — FXM Clinical Research Miramar LLC
The FDA completed an inspection of FXM Clinical Research Miramar LLC on April 5, 2024 in Miramar, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miramar, FL (United States)
Additional Details
Clinical BA/BE